Release test results
99.751%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 20.14 mg
Related impurities (total)0.249%
Endotoxin<1.0 EU/mg
HPLC retention time6.46 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundWolverine
Presentation20 MG
Lot numberRGX-26-WOLVERINE-760
COA numberNS-2026-05155
Test date14 Apr 2026
Release date17 Apr 2026
Independent labNordicstar Labs
StatusSuperseded
Wolverine — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-WOLVERINE-1039 | 10 MG | Jul 19, 2026 | 99.722% | Current |
| RGX-26-WOLVERINE-1040 | 20 MG | Jul 19, 2026 | 99.760% | Current |
| RGX-26-WOLVERINE-760 this lot | 20 MG | Apr 14, 2026 | 99.751% | Superseded |
| RGX-26-WOLVERINE-761 | 10 MG | Apr 8, 2026 | 99.758% | Superseded |
| RGX-26-WOLVERINE-661 | 10 MG | Jan 15, 2026 | 99.713% | Superseded |
| RGX-26-WOLVERINE-660 | 20 MG | Jan 13, 2026 | 99.568% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →